Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for CBSTQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
September 30, 2025 23.10%
June 30, 2025 14.72%
March 31, 2025 28.86%
December 31, 2024 29.94%
September 30, 2024 32.93%
June 30, 2024 33.04%
March 31, 2024 29.47%
December 31, 2023 33.98%
September 30, 2023 25.30%
June 30, 2023 37.90%
March 31, 2023 31.44%
December 31, 2022 21.82%
September 30, 2022 28.24%
June 30, 2022 28.52%
March 31, 2022 33.49%
Date Value
December 31, 2021 41.11%
September 30, 2021 37.70%
June 30, 2021 35.95%
March 31, 2021 33.42%
December 31, 2020 38.26%
September 30, 2020 32.47%
June 30, 2020 30.52%
March 31, 2020 25.84%
December 31, 2019 19.20%
September 30, 2019 18.64%
June 30, 2019 25.09%
March 31, 2019
December 31, 2018 -197.9%
September 30, 2018 -15.81K%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
cbdMD, Inc. 50.03%
MedMen Enterprises, Inc. --
Australis Capital, Inc. --
ANI Pharmaceuticals, Inc. 54.97%
Corcept Therapeutics, Inc. 98.41%